Compounds > bufalin

bufalin and Colorectal Cancer

bufalin has been researched along with Colorectal Cancer in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (50.00)24.3611
2020's5 (50.00)2.80

Authors

AuthorsStudies
Gao, F; Li, Y; Liu, C; Ma, S; Shang, J; Sun, Y; Wu, H; Yin, P; Yuan, Z; Zhan, Y1
Cao, Z; Chandrakesan, P; Chen, H; Chen, X; Ding, L; Du, J; Feng, H; Liao, Z; Lu, Q; Qu, D; Weygant, N; Yang, Y1
Cao, Y; Chen, J; Chen, Y; Li, S; Li, W; Tang, D; Wang, H; Wu, W; Xu, K; Yang, J; Yin, P; Yu, K1
Cao, Y; Fan, G; Le, VM; Li, W; Ly, HT; Qiu, Y; Wang, H; Wang, Z; Xu, J; Xu, K; Yin, P; Yuan, Z; Zhan, Y1
Cao, Y; Chen, J; He, J; Jia, L; Li, W; Li, Y; Liu, H; Qiu, Y; Wang, H; Wu, R; Xu, K; Yin, P; Yuan, Z; Zhan, Y1
He, X; Liu, C; Qiu, YY; Shi, XJ; Xu, K; Yin, PH; Yu, H; Yuan, YX; Yuan, ZT; Zou, Y1
Gao, H; Qiu, Y; Sun, J; Tang, Q; Xu, J; Xu, K; Yin, P1
Feng, W; Hu, Q; Hu, SJ; Liang, B; Peng, W; Qiu, YY; Tang, QF; Yin, PH1
Bao, YJ; Duan, YR; Guo, XL; Hu, Q; Liang, B; Peng, ZH; Sun, Y; Xie, DH; Yin, PH; Zhou, M1
Cui, X; Deng, W; Feng, X; Gao, Y; Guo, W; Hao, J; Jiang, W; Li, J; Liao, Y; Liu, G; Tai, Y; Xie, Y; Yu, W; Zhang, N; Zhao, X1

Other Studies

10 other study(ies) available for bufalin and Colorectal Cancer

ArticleYear
Bufalin exacerbates Photodynamic therapy of colorectal cancer by targeting SRC-3/HIF-1α pathway.
    International journal of pharmaceutics, 2022, Aug-25, Volume: 624

    Topics: Animals; Bufanolides; Cell Line, Tumor; Colorectal Neoplasms; Hypoxia; Mice; Neovascularization, Pathologic; Photochemotherapy; Photosensitizing Agents

2022
Bufalin Inhibits Tumorigenesis, Stemness, and Epithelial-Mesenchymal Transition in Colorectal Cancer through a C-Kit/Slug Signaling Axis.
    International journal of molecular sciences, 2022, Nov-01, Volume: 23, Issue:21

    Topics: Cadherins; Carcinogenesis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Transformation, Neoplastic; Colorectal Neoplasms; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Humans; Neoplastic Stem Cells

2022
Bufalin reverses cancer-associated fibroblast-mediated colorectal cancer metastasis by inhibiting the STAT3 signaling pathway.
    Apoptosis : an international journal on programmed cell death, 2023, Volume: 28, Issue:3-4

    Topics: Apoptosis; Cancer-Associated Fibroblasts; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Humans; Signal Transduction; STAT3 Transcription Factor; Tumor Microenvironment

2023
Bufalin reverses multidrug resistance by regulating stemness through the CD133/nuclear factor-κB/MDR1 pathway in colorectal cancer.
    Cancer science, 2020, Volume: 111, Issue:5

    Topics: AC133 Antigen; Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; Bufanolides; Cell Line, Tumor; Colorectal Neoplasms; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Therapy, Combination; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Nude; Neoplastic Stem Cells; Signal Transduction; Transcription Factor RelA

2020
Bufalin targets the SRC-3/MIF pathway in chemoresistant cells to regulate M2 macrophage polarization in colorectal cancer.
    Cancer letters, 2021, 08-10, Volume: 513

    Topics: Animals; Bufanolides; Colorectal Neoplasms; Humans; Macrophage Migration-Inhibitory Factors; Macrophages; Mice; Sodium-Potassium-Exchanging ATPase

2021
Bufalin reverses ABCB1-mediated drug resistance in colorectal cancer.
    Oncotarget, 2017, Jul-18, Volume: 8, Issue:29

    Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bufanolides; Cell Line, Tumor; Cell Membrane Permeability; Colorectal Neoplasms; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Enzyme Activation; Gene Expression Regulation, Neoplastic; Humans; Mice; Models, Molecular; Molecular Conformation; Protein Binding; Xenograft Model Antitumor Assays

2017
Bufalin reverses acquired drug resistance by inhibiting stemness in colorectal cancer cells.
    Oncology reports, 2017, Volume: 38, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bufanolides; Cell Proliferation; Cisplatin; Colorectal Neoplasms; Drug Resistance, Neoplasm; HCT116 Cells; Humans; Neoplastic Stem Cells; Signal Transduction

2017
MicroRNA-497 and bufalin act synergistically to inhibit colorectal cancer metastasis.
    Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2014, Volume: 35, Issue:3

    Topics: Animals; Antineoplastic Agents; Blotting, Western; Bufanolides; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Humans; Male; Mice; Mice, Nude; MicroRNAs; Neoplasm Invasiveness; Neoplasm Metastasis; Neovascularization, Pathologic; Real-Time Polymerase Chain Reaction

2014
Preparation of bufalin-loaded pluronic polyetherimide nanoparticles, cellular uptake, distribution, and effect on colorectal cancer.
    International journal of nanomedicine, 2014, Volume: 9

    Topics: Animals; Antineoplastic Agents; Bufanolides; Colorectal Neoplasms; Drug Carriers; HCT116 Cells; Humans; Liver; Male; Mice; Mice, Nude; Nanoparticles; Particle Size; Poloxamer; Polymers; Xenograft Model Antitumor Assays

2014
Bufalin Inhibits hTERT Expression and Colorectal Cancer Cell Growth by Targeting CPSF4.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2016, Volume: 40, Issue:6

    Topics: Apoptosis; Bufanolides; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cleavage And Polyadenylation Specificity Factor; Colorectal Neoplasms; Humans; Promoter Regions, Genetic; Protein Binding; Telomerase

2016